X-linked inhibitor of apoptosis protein mediates tumor cell resistance to antibody-dependent cellular cytotoxicity
Myron K. Evans, Gayathri R. Devi(Medical University of South Carolina), Scott J. Sauer(Duke Medical Center), Michael A. Morse(Duke Medical Center), Sritama Nath(University of North Carolina at Charlotte), Timothy J. Robinson(Duke Medical Center)
Cited by 52
Related Papers
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
|The Lancet Oncology|2017|2.8k
Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-Galactose
|New England Journal of Medicine|2008|1.5k
Three-dimensional culture systems in cancer research: Focus on tumor spheroid model
|Pharmacology & Therapeutics|2016|921
MUC1: a multifaceted oncoprotein with a key role in cancer progression
|Trends in Molecular Medicine|2014|854
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636